Skip to content

A Real-World Study on the Role of Shouhui Laxative Capsule in the Management of Elderly Patients with Chronic Diseases and Comorbidities Based on the Concept of "Spleen as the Root of Postnatal Development"

A Real-World Study on the Role of Shouhui Laxative Capsule in the Management of Elderly Patients with Chronic Diseases and Comorbidities Based on the Concept of "Spleen as the Root of Postnatal Development"

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026001254
Enrollment
Unknown
Registered
2026-05-18
Start date
2026-05-30
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly with multiple chronic diseases

Interventions

Shouhui Group:Routine treatment for elderly with comorbid chronic diseases plus Shouhui Laxative Capsules, 1 capsule per dose, 3 times daily.
Non-Feishouhui Group:The Routine Treatment of Chronic Diseases with Comorbidities in the Elderly

Sponsors

Shandong University of Traditional Chinese Medicine Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: Eligibility for inclusion in this study is contingent upon the following conditions being met: (1) Elderly patients suffering from multiple chronic diseases; (2) Patients diagnosed with qi and yin deficiency combined with internal toxicity according to traditional Chinese medicine; (3) Aged between 60 and 100 years old, regardless of gender; (4) Signed an informed consent form.

Exclusion criteria

Exclusion criteria: Any individual with any of the following conditions is not eligible to participate in this study: (1) Patients who have participated in other clinical trials within the past 3 months; (2) Individuals with allergic constitutions or a history of allergy to any components of the Shuhui Laxative Capsules; (3) Patients with impaired liver or kidney function; (4) Individuals with dementia, consciousness disorders, or other conditions that prevent them from cooperating with this study.

Design outcomes

Primary

MeasureTime frame
Stool Gut Microbiota Analysis;

Secondary

MeasureTime frame
Monoamine neurotransmitters (norepinephrine, dopamine, serotonin);Cytokine 12-item panel;Fasting Blood Glucose;Fasting Insulin;Vascular Endothelial Growth Factor;Blood nitric oxide;

Countries

China

Contacts

Public ContactYan Xiaoyan

Shandong University of Traditional Chinese Medicine Affiliated Hospital

Sharon.yan@163.com18653125970

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026